Skip to content
10-K

Annual Report

Oragenics, Inc. OGEN

0001493152-26-010282

← back to feed
Filed
Mar 16, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 13, 2026 4.34M sh
Shares Diluted FY 2025 · Dec 31, 2025 2.16M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 220.73K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$9.25M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$8.6M
Short Term Investments FY 2025 · Dec 31, 2025 $4M
Cash And Equivalents FY 2025 · Dec 31, 2025 $4.4M
Cash And Equivalents FY 2025 · Dec 31, 2024 $864.84K
Stockholders Equity FY 2025 · Dec 31, 2025 $8.28M
Stockholders Equity FY 2025 · Dec 31, 2024 −$211.89K
Stockholders Equity FY 2025 · Dec 31, 2023 $3.17M
Total Liabilities FY 2025 · Dec 31, 2025 $1.79M
Total Liabilities FY 2025 · Dec 31, 2024 $1.68M
Current Assets FY 2025 · Dec 31, 2025 $10.07M
Current Assets FY 2025 · Dec 31, 2024 $1.47M
Total Assets FY 2025 · Dec 31, 2025 $10.07M
Total Assets FY 2025 · Dec 31, 2024 $1.47M
Eps Diluted FY 2025 · Dec 31, 2025 −$4.56
Eps Diluted restated FY 2025 · Dec 31, 2024 −$47.88
Eps Basic FY 2025 · Dec 31, 2025 −$4.56
Eps Basic restated FY 2025 · Dec 31, 2024 −$47.88
Rd Expense FY 2025 · Dec 31, 2025 $2.39M
Rd Expense FY 2025 · Dec 31, 2024 $4.11M
Net Income FY 2025 · Dec 31, 2025 −$9.84M
Net Income FY 2025 · Dec 31, 2024 −$10.57M
Operating Income FY 2025 · Dec 31, 2025 −$9.36M
Operating Income FY 2025 · Dec 31, 2024 −$10.56M